Healthcare

Acteon

A French medtech company, specialized in high technology
dental and medical devices
Logo
Nature of the deal:

Unitranche

Logo
Investment date

2016, 2018

Logo
Country

France

Logo
Status

In portfolio

ACTEON creates, develops and distributes high-tech dental and medical devices that enable dentists and surgeons to implement less invasive, safer and quicker operating protocols that are less traumatic for their patients. Based in Merignac near Bordeaux, the group employs almost 750 people and is represented in over 100 countries worldwide.

 

ACTEON, a leader in high frequency ultrasonics and digital medical imaging, is split into 4 business units: dental equipment, medical equipment, imaging and pharma. Boasting significant technical know-how, ACTEON ’s products are renowned by practitioners for their quality, reliability and innovation. ACTEON employs highly trained technical and sales teams and has set up a powerful distribution network worldwide.

 

 

Context & Ambition

 

In 2016, the Group was looking for a partner to finance a new LBO as well as potential acquisitions as Bridgepoint took over the group alongside the management team. The group wanted to speed up its development by expanding the sales team, broadening the product range and extending its geographic footprint through external growth. In 2018, Bridgepoint sold its equity stake to Dentressangle.

Our Role

In 2016, CAPZA arranged the initial debt financing when Bridgepoint acquired the group alongside the management team.

 

The unitranche facility also included an acquisition facility, which was drawn in 2017, as Acteon acquired Prodont Holliger, an expert in dental manual instruments. In 2018, we financed Dentressangle’s acquisition and the subsequent development strategy. The group aims to enter the top 5 worldwide for dental imaging and strives to equip 33% of dental practices with ultrasonic surgical devices.

Private Debt
Private Debt
Leading mid-market
direct lender
Read more
113 transactions since 2005
Source: CAPZA as of Decembre 2021
Newsroom
  • 21
    Jun’ 2022
    CAPZA acquires a stake in Nutravalia
    CAPZA acquires a significant stake in Nutravalia, a French laboratory specialising in food supplements and parapharmacy products.
    Read more
  • 14
    Jun’ 2022
    Record-breaking fundraising of nearly €600 million for Artemid
    CAPZA announces the successful closing of the Artemid Senior Loan III (ASL III) private debt fund
    Read more
  • 1
    Jun’ 2022
    A successful first closing for CAPZA 6 Private Debt
    CAPZA successfully raises ca. €1.2bn in the first closing of its unitranche fund, CAPZA 6 Private Debt
    Read more
  • 12
    Apr’ 2022
    CAPZA Transition supports Tevah Systèmes
    CAPZA acquires a stake in Tevah Systèmes, an independent distributor of security systems.
    Read more